Peter Iversen Selected Research

bicalutamide (Casodex)

7/2015	Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: long-term follow-up of the SPCG-6 study.
4/2010	Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years.
3/2008	The Early Prostate Cancer program: bicalutamide in nonmetastatic prostate cancer.
9/2006	Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration.
3/2006	The third analysis of the bicalutamide Early Prostate Cancer programme.
2/2006	Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer.
1/2006	Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer: updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years.
7/2005	Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme.
11/2004	Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years.
11/2004	Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Iversen Research Topics

Disease

73	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2002
21	Neoplasms (Cancer) 01/2022 - 11/2004
7	Neoplasm Metastasis (Metastasis) 10/2018 - 01/2008
7	Disease Progression 01/2018 - 08/2002
7	Hepatic Encephalopathy 12/2015 - 07/2006
5	Fibrosis (Cirrhosis) 01/2014 - 07/2006
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 01/2015
4	Margins of Excision 06/2014 - 06/2012
3	Male Breast Neoplasms (Male Breast Cancer) 01/2020 - 01/2018
3	Insulin Resistance 01/2019 - 10/2013
3	Fatigue 01/2017 - 09/2002
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2014 - 03/2009
3	Mastodynia 04/2010 - 08/2002
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 11/2011
2	Heart Failure 01/2019 - 01/2018
2	Hyperammonemia 03/2009 - 06/2007
2	Osteoporosis 01/2008 - 09/2002
2	Carcinoma (Carcinomatosis) 04/2006 - 03/2005
2	Gynecomastia 11/2004 - 08/2002
1	Primary Hyperparathyroidism 01/2022
1	Obesity 01/2020
1	Treatment-Resistant Depressive Disorder 01/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	follicular Thyroid cancer 01/2018
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2018
1	Prediabetic State (Prediabetes) 01/2018
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Back Pain (Backache) 01/2017
1	Infections 01/2017
1	Constipation 01/2017
1	Arthralgia (Joint Pain) 01/2017
1	Bone Diseases (Bone Disease) 10/2016
1	Pathologic Constriction (Stenosis) 08/2016
1	Anastomotic Leak 08/2016
1	Hemorrhage 02/2015
1	Flatulence 02/2015

Drug/Important Bio-Agent (IBA)

18	Prostate-Specific Antigen (Semenogelase)IBA 11/2019 - 05/2004
14	bicalutamide (Casodex)FDA LinkGeneric 07/2015 - 08/2002
10	AndrogensIBA 04/2016 - 01/2002
9	Testosterone (Sustanon)FDA Link 01/2020 - 02/2012
9	enzalutamideIBA 11/2019 - 05/2014
8	Hormones (Hormone)IBA 01/2018 - 12/2009
6	Androgen Antagonists (Antiandrogens)IBA 11/2018 - 12/2003
6	Androgen Receptors (Androgen Receptor)IBA 11/2018 - 05/2014
5	Biomarkers (Surrogate Marker)IBA 02/2016 - 04/2006
4	Finasteride (Propecia)FDA LinkGeneric 01/2020 - 02/2004
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 10/2013
4	AmmoniaIBA 01/2014 - 07/2006
3	Edotreotide (SMT 487)IBA 06/2020 - 01/2015
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2016 - 12/2009
3	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 04/2016 - 12/2009
3	Urokinase Plasminogen Activator ReceptorsIBA 01/2016 - 03/2005
3	Proteins (Proteins, Gene)FDA Link 10/2015 - 11/2014
3	erucylphosphocholineIBA 02/2006 - 07/2005
2	carbon-11 methionineIBA 01/2022 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 11/2018
2	Acetates (Acetic Acid Esters)FDA Link 12/2015 - 01/2014
2	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2015 - 01/2009
2	Docetaxel (Taxotere)FDA Link 06/2014 - 05/2014
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2011 - 03/2005
2	Oxygen (Dioxygen)IBA 03/2010 - 03/2009
2	Tricarboxylic AcidsIBA 03/2009 - 06/2007
2	polyestradiol phosphate (Estradurin)FDA Link 01/2008 - 01/2002
2	Estrogens (Estrogen)FDA Link 01/2008 - 01/2002
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2022
1	Peptide Receptors (Peptide Receptor)IBA 06/2020
1	Radioisotopes (Radionuclides)IBA 06/2020
1	AntigensIBA 05/2020
1	PerfumeIBA 01/2020
1	Liraglutide FDA Link 01/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Methionine (L-Methionine)FDA Link 01/2018
1	fluorocholineIBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Norfloxacin FDA Link 01/2017
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2017
1	Chloramphenicol (Chloromycetin)FDA Link 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2016
1	LeptinIBA 02/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2016
1	AdiponectinIBA 02/2016
1	Interleukin-6 (Interleukin 6)IBA 02/2016
1	Insulin (Novolin)FDA Link 02/2016
1	Triglycerides (Triacylglycerol)IBA 02/2016
1	Insulin-Like Growth Factor Binding Protein 1IBA 02/2016
1	VaccinesIBA 05/2015

Therapy/Procedure

32	Prostatectomy (Retropubic Prostatectomy) 05/2020 - 08/2002
24	Therapeutics 01/2022 - 01/2002
14	Castration 11/2019 - 09/2002
10	Radiotherapy 01/2022 - 08/2002
6	Drug Therapy (Chemotherapy) 11/2019 - 02/2012
2	Endurance Training 02/2016 - 10/2013
2	Cryotherapy (Therapy, Cold) 06/2011 - 04/2011
1	Parathyroidectomy 01/2022
1	Bathroom Equipment 02/2015
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2015